PrEP decision aid for Black women facing domestic violence in Baltimore
Development and Evaluation of a PrEP Decision Aid for Women Seeking Domestic Violence Services in Baltimore
This study is testing a special tool to help Black women who have faced domestic violence in Baltimore make informed choices about using PrEP to prevent HIV.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Johns Hopkins Bloomberg School of Public Health Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Trial ID | NCT05614492 on ClinicalTrials.gov |
What this trial studies
This study aims to develop and evaluate a tailored decision aid for pre-exposure prophylaxis (PrEP) specifically for Black women who have experienced intimate partner violence. It tests three delivery methods: an individual tool, a shared decision-making tool with a domestic violence advocate, and generalized information. The goal is to address cultural and structural barriers to PrEP awareness and access, ultimately increasing its uptake among this vulnerable population. The research is guided by the Consolidated Framework for Implementation Research (CFIR) and involves a randomized trial to assess effectiveness.
Who should consider this trial
Good fit: Ideal candidates for this study are Black women aged 18 and older who have experienced intimate partner violence in the past year and are HIV negative.
Not a fit: Patients currently using PrEP or those unable to provide consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve PrEP access and awareness among Black women affected by intimate partner violence, thereby reducing their risk of HIV.
How similar studies have performed: While there have been studies on PrEP uptake, this specific approach tailored to IPV-exposed Black women is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age 18 years or older * self-identification as cisgender female * IPV-exposed (i.e., at least one physical, sexual, or psychological IPV victimization experience by a male partner) in the past 12 months * self-reported HIV negative * English- and/or Spanish-speaking * self-identify as Black or African American Exclusion Criteria: * Currently using PrEP * Unable to provide consent * Participated in formative research for this study
Where this trial is running
Baltimore, Maryland
- Springboard Community Services - Baltimore City Office — Baltimore, Maryland, United States (Recruiting)
Study contacts
- Principal investigator: Tiara Willie, PhD, MA — Johns Hopkins Bloomberg School of Public Health
- Study coordinator: Tiara Willie, Ph.D, MA
- Email: twillie2@jhu.edu
- Phone: 410-614-2686
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.